African Continental Free Trade Area (AfCFTA) Secretariat’s Post

Arezou Mehrabi has a spellbinding #supplychain case study. It transpired, of all places, in #Iran. It includes major challenges in #outsourcing #manufacturing to a partner #CDMO for a top-ten #pharma (Sanofi, to be exact). Our protagonist is a woman who took leadership within a male-dominated workplace, country, and entire region. Women In Bio - Engage. Educate. Empower. #pharmaceuticalindustry https://lnkd.in/eeeUcCRp

Our Beyond Borders: EY Biotechnology Report 2024 reveals biotech's resilience, with US and European firms expecting a recovery in investment within 6-12 months as interest rates drop. While some companies thrive on innovation, others need strong management and clinical data to secure investment. Highlighting recovery driven by faith in new advancements, the report offers insights on deals, IPOs, financial performance, and emerging tech like #AI and oncology breakthroughs, providing strategic guidance for growth. Check out the full report here: https://lnkd.in/eGtAPuCx #Biotech #Innovation Rich Ramko, Ashwin Singhania, Arda Ural, MSc, MBA, PhD

36% of senior leaders in pharma agree that funding is the biggest barrier to digital adoption and transformation, despite increasing spend. Despite such challenges, the same report from Graphite Digital reveals that 51% of pharma companies are poised to boost their digital investments in the next two years, while the rest will maintain current spending levels. It is important to create a clear connection between the business goals and project outcomes to ensure that digital initiatives benefit both the organisation and its customers.

📢 We are excited to announce our partnership with Johnson & Johnson for the upcoming event! 🤝🌍   𝗘𝗜𝗖 𝗮𝗻𝗱 𝗝𝗼𝗵𝗻𝘀𝗼𝗻 𝗮𝗻𝗱 𝗝𝗼𝗵𝗻𝘀𝗼𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿 𝗗𝗮𝘆, 𝗽𝗼𝘄𝗲𝗿𝗲𝗱 𝗯𝘆 𝗘𝘂𝗿𝗼𝗾𝘂𝗶𝘁𝘆 - 𝗕𝗽𝗶𝗳𝗿𝗮𝗻𝗰𝗲.   This partnership represents a unique opportunity to strengthen innovation, accelerate healthcare advancements, build bridges between stakeholders, and drive economic growth in the healthcare sector!   Highlights of the event: ✔ 20 EIC Accelerator Companies with #Biotech, #Pharmaceutical, #medtech and #digitalhealth will be pitching. ✔ Over 60 funds will be attending the event. ✔ Representatives from the EIB, the EIC, and Bpifrance will also be present. 🔹 Stéphane Ouaki 🇺🇦🇪🇺, Head of Department at European Innovation Council and SMEs Executive Agency (EISMEA). 🔹 Lilian Alcaraz, VP Early Innovation Partnering EMEA at Johnson & Johnson. 🔹 Pascal Lagarde, Director - Head for International Affairs, Strategy, Research, and Development at Bpifrance. 🔹 Anna Stodolkiewicz, CFA, Head of EIC Fund Investment Unit at the European Investment Bank (EIB). 🔹 Marielle Mailhes, Investment Director - Life Sciences at Bpifrance. 🔹 Gilles Le Cocguen, Director of EuroQuity - Bpifrance.   Don't miss out on this opportunity to connect with 20 innovative companies, industry experts and investors. See you there! 👋   #HealthTech #biotech #medtech #eicAccelerator #EUeic #Healthcare

2025 Stifel Performance Trends in Pharma and Biotech Easy to digest. 📘 Download the full report here: https://lnkd.in/gGuV4Jjh 💡 What This Report Adds ✔ Strategic frameworks to guide decision-making. ✔ Market opportunities to identify growth areas. ✔ Insights tailored for investors, executives, and entrepreneurs. #Pharma #Biotech Mellalta Meets

We are living in a pivotal moment for Ireland’s biopharma sector— but what’s next? A huge thank you to Niall Cunneen, Associate Partner at Sia Partners, for breaking down the opportunities and challenges shaping the future of Irish biopharma. His session explored how investment, innovation, & policy shifts are driving change and what companies must do to stay competitive in an increasingly complex global landscape. #BioPharmaExpo #BiopharmaStrategy #IndustryGrowth #LifeSciences #MarketTrends #SiaPartners | Colin Murphy | Mark Hutchinson | Sylvia McCarthy | Susan J. | Matthew Scott

Future of Biotech with innovation

The Global Development Hub at Imperial College London runs a series of high impact policy memos that profile -- in lay accessible form – emerging areas of science and technology that can impact on development challenges. 💉 Challenge: Africa produces less than 1% of the world’s total vaccine supply. 🔬 Technology: Plant-based vaccine technology offers a cost-effective way to increase access to vaccines and biologics Read about the transformational potential of the Chanjo Hub led by Prof. Faith Osier and its work to develop vaccines for diseases with epidemic potential in low and middle-income countries (LMICs). 📝 https://lnkd.in/esZ8sPPh

Sustainability is more than just a goal, it's becoming a defining factor in the biopharma industry. 🌍 A recent comprehensive survey of over 800 biopharma executives highlights the growing importance of sustainability, with 62% of companies identifying it as a top priority. The benefits are clear: improved brand reputation, increased profits, higher share prices, and enhanced talent attraction. Executives like David Butler of Hongene Biotech emphasise the strategic and financial sense of pursuing sustainable practices, citing long-term cost savings as a key driver. The potential rewards for companies, and for the planet are immense. ______________ Do you see any challenges that could come with these opportunities? Comment your thoughts below! #biopharma #iPharm #sustainability